On January 12, 2024, Adhera Therapeutics, Inc. received notice from Zahed Subhan that he was resigning as the company?s Chief Executive Officer and as a member of the Board of Directors. Mr. Subhan?s decision to resign as Chief Executive Officer and member of the company?s Board of Directors was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies, or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 USD | -32.58% | -10.45% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 69.76K | |
-1.04% | 104B | |
+6.24% | 97.47B | |
+5.71% | 22.25B | |
-13.32% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.23% | 16.36B | |
+8.58% | 14.39B | |
+39.58% | 12.37B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Announces the Resignation of Zahed Subhan as Chief Executive Officer